Search

everythinglearnresearchcommunity

for

Search:↓

Many women experience significant hair loss during menopause, and topical minoxidil is an effective treatment.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

Biotin doesn't help hair growth in healthy people and can cause health risks if overused.

Spironolactone does not increase the risk of breast cancer recurrence.

The document suggests a clinical trial to accurately determine if PRP is an effective treatment for a common type of hair loss in men.

Early-onset male baldness is significantly linked to a higher risk of metabolic syndrome.

Most Cochrane Skin Group reviews are helpful for improving dermatology practices, but some lack enough evidence for clinical recommendations.

Spironolactone is safe for breast cancer survivors with alopecia and does not increase cancer risk.

Hair mineral analysis might help diagnose diseases early, but standard methods are needed.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Open brow lifts are still important and effective in cosmetic surgery.

Chemotherapy may help with survival in children with medulloblastoma, but more research is needed.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Androgenetic alopecia negatively affects quality of life and self-esteem, especially in women, but not depression.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Some nutritional supplements may help treat hair loss with generally mild side effects.

Low-level light/laser therapy is effective in treating male and female pattern hair loss without side effects.

Imiquimod may be a better non-surgical treatment for cervical pre-cancer, but its effectiveness for vaginal pre-cancer is unclear, and it has some side effects.

Topical minoxidil effectively treats Female Pattern Hair Loss in women of all ages and hormone levels, but evidence for antiandrogens is limited.

Combining two treatments for hair loss works better than using just one.

PCOS is a major cause of infertility in women of childbearing age.

Topical caffeine improves hair loss intensity, speed, and shedding, and works better with minoxidil/azelaic acid.

Patients with PCOS face poor communication and support from healthcare professionals.

Herbal treatments can help manage PCOS symptoms.

Fat stem cell treatment is safe and increases hair density for hair loss, but more research is needed.

Bioprinting could greatly improve health outcomes but faces challenges like material choice and ensuring long-term survival of printed tissues.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.